NeuroNexus Technologies and Philips partner to research deep brain stimulation devices
Philips, November 18, 2008
NeuroNexus Technologies and Philips Research have announced that they have signed a joint research agreement to develop next-generation deep brain stimulation devices with the ambition to improve the treatment of neurological diseases and psychiatric disorders. The two companies aim to show the technical feasibility of highly programmable and MRI-safe deep brain stimulation devices, according to a release. Their initial research will aim to meet the functional requirements of a deep brain stimulation device for the treatment of Parkinson?s disease.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Revenue Cycles Get a Boost from Simple JPEG Files
- Healthcare Costs Start With What We Eat
- CA Fines 8 Hospitals for Medical Errors
- Handshaking Spreads Germs. Get Over It.
- Centralizing the Revenue Cycle Protects the Bottom Line